Authors:
VANGELDER T
BALK AHMM
JONKMAN FAM
ZIETSE R
ZONDERVAN P
HESSE CJ
VAESSEN LMB
MOCHTAR B
WEIMAR W
Citation: T. Vangelder et al., A RANDOMIZED TRIAL COMPARING SAFETY AND EFFICACY OF OKT3 AND A MONOCLONAL ANTI-INTERLEUKIN-8 RECEPTOR ANTIBODY (BT563) IN THE PREVENTION OFACUTE REJECTION AFTER HEART-TRANSPLANTATION, Transplantation, 62(1), 1996, pp. 51-55
Authors:
VANGELDER T
MULDER AH
BALK AHMM
MOCHTAR B
HESSE CJ
BAAN CC
VAESSEN LMB
WEIMAR W
Citation: T. Vangelder et al., INTEGRAFT MONITORING OF REJECTION AFTER PROPHYLACTIC TREATMENT WITH MONOCLONAL ANTI-INTERLEUKIN-2 RECEPTOR ANTIBODY (BT563) IN HEART-TRANSPLANT RECIPIENTS, The Journal of heart and lung transplantation, 14(2), 1995, pp. 346-350
Authors:
MARSMAN WA
VANGELDER T
MULDER AH
IJZERMANS JNM
ZIETSE R
WEIMAR W
Citation: Wa. Marsman et al., SUCCESSFUL TREATMENT OF KAPOSIS-SARCOMA IN A RENAL-ALLOGRAFT RECIPIENT, Nephrology, dialysis, transplantation, 10(6), 1995, pp. 900-901
Authors:
HESSE CJ
VANGELDER T
VAESSEN LMB
KNOOP CJ
BALK AHMM
YZERMANS JNM
JUTTE NHPM
WEIMAR W
Citation: Cj. Hesse et al., PHARMACODYNAMICS OF PROPHYLACTIC ANTIREJECTION THERAPY WITH AN ANTI-INTERLEUKIN-2 RECEPTOR MONOCLONAL-ANTIBODY (BT563) AFTER HEART AND KIDNEY-TRANSPLANTATION, Immunopharmacology, 30(3), 1995, pp. 237-246
Authors:
VANGELDER T
VERHOEVEN GT
DEJONG P
OEI HY
KRENNING EP
VUZEVSKI VD
VANDENMEIRACKER AH
Citation: T. Vangelder et al., DOPAMINE-PRODUCING PARAGANGLIOMA NOT VISUALIZED BY IODINE-123-MIBG SCINTIGRAPHY, The Journal of nuclear medicine, 36(4), 1995, pp. 620-622
Authors:
VANGELDER T
ZIETSE R
YZERMANS JNM
VAESSEN LMB
MULDER AH
WEIMAR W
Citation: T. Vangelder et al., MONOCLONAL ANTI-INTERLEUKIN-2 RECEPTOR ANTIBODY (BT563) PREVENTS EARLY REJECTION AFTER KIDNEY-TRANSPLANTATION - A DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL, Kidney international, 47(2), 1995, pp. 708-708
Authors:
VANGELDER T
KNOOP CJ
HESSE CJ
VAESSEN LMB
BALK AHMM
YZERMANS JNM
WEIMAR W
Citation: T. Vangelder et al., PERIPHERAL-BLOOD MONITORING DURING AND AFTER REJECTION-PROPHYLAXIS WITH A MONOCLONAL ANTI-INTERLEUKIN-2-RECEPTOR ANTIBODY IN KIDNEY AND HEART-TRANSPLANT RECIPIENTS, Transplantation proceedings, 27(1), 1995, pp. 856-858
Authors:
VANGELDER T
ZIETSE R
MULDER AH
YZERMANS JNM
HESSE CJ
VAESSEN LMB
WEIMAR W
Citation: T. Vangelder et al., A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF MONOCLONAL ANTI-INTERLEUKIN-2 RECEPTOR ANTIBODY (BT563) ADMINISTRATION TO PREVENT ACUTE REJECTION AFTER KIDNEY-TRANSPLANTATION, Transplantation, 60(3), 1995, pp. 248-252
Citation: T. Vangelder et al., PROGNOSTIC FACTORS AND SURVIVAL IN MALIGNANT PLEURAL MESOTHELIOMA, The European respiratory journal, 7(6), 1994, pp. 1035-1038
Authors:
VANGELDER T
KROES LCM
MULDER A
GRATAMA JW
WEIMAR W
Citation: T. Vangelder et al., A LIVING-RELATED KIDNEY DONOR AS THE SOURCE OF A NEARLY FATAL PRIMARYEPSTEIN-BARR-VIRUS INFECTION FOLLOWING TRANSPLANTATION, Transplantation, 58(7), 1994, pp. 852-855
Citation: T. Vangelder, CONNECTIONISM AND THE MIND-BODY PROBLEM - EXPOSING THE DISTINCTION BETWEEN MIND AND COGNITION, Artificial intelligence review, 7(5), 1993, pp. 355-369